NOVEL CHK1 INHIBITOR MU380 EXHIBITS SIGNIFICANT SINGLE-AGENT ACTIVITY IN TP53-MUTATED CHRONIC LYMPHOCYTIC LEUKEMIA CELLS

Prashant Khirsariya^a, Miroslav Boudný^a, Jana Zemanová^a, Jan Verner^a, Martin Trbušek^a, Kamil Paruch^a

^a Masaryk University, Brno, Czech Republic

PDF-Abstract